186 related articles for article (PubMed ID: 24532190)
21. DNA ploidy heterogeneity in endometrial carcinoma: comparison between curettage and hysterectomy specimens.
Pradhan M; Abeler VM; Davidson B; Kildal W; Nybøen A; Tropé CG; Risberg B; Danielsen HE
Int J Gynecol Pathol; 2010 Nov; 29(6):572-8. PubMed ID: 20881853
[TBL] [Abstract][Full Text] [Related]
22. [Prognostic evaluation of endometrial carcinoma by DNA content and histologic factors].
Shimizu K
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Apr; 47(4):413-8. PubMed ID: 7730696
[TBL] [Abstract][Full Text] [Related]
23. Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis.
Pelletier MP; Edwardes MD; Michel RP; Halwani F; Morin JE
Can J Surg; 2001 Jun; 44(3):180-8. PubMed ID: 11407827
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors in surgical stage I endometrial carcinoma.
Lundgren C; Auer G; Frankendal B; Nilsson B; Nordström B
Acta Oncol; 2004; 43(1):49-56. PubMed ID: 15068320
[TBL] [Abstract][Full Text] [Related]
25. Changes in Chromatin Structure in Curettage Specimens Identifies High-Risk Patients in Endometrial Cancer.
Hveem TS; Njølstad TS; Nielsen B; Syvertsen RA; Nesheim JA; Kjæreng ML; Kildal W; Pradhan M; Marcickiewicz J; Tingulstad S; Staff AC; Haugland HK; Eraker R; Oddenes K; Rokne JA; Tjugum J; Lode MS; Amant F; Werner HM; Bjørge L; Albregtsen F; Liestøl K; Salvesen HB; Trovik J; Danielsen HE;
Cancer Epidemiol Biomarkers Prev; 2017 Jan; 26(1):61-67. PubMed ID: 27587790
[TBL] [Abstract][Full Text] [Related]
26. DNA ploidy in curettage specimens identifies high-risk patients and lymph node metastasis in endometrial cancer.
Njølstad TS; Trovik J; Hveem TS; Kjæreng ML; Kildal W; Pradhan M; Marcickiewicz J; Tingulstad S; Staff AC; Haugland HK; Eraker R; Oddenes K; Rokne JA; Tjugum J; Lode MS; ; Amant F; Werner HM; Salvesen HB; Danielsen HE
Br J Cancer; 2015 May; 112(10):1656-64. PubMed ID: 25897678
[TBL] [Abstract][Full Text] [Related]
27. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
28. The relationship between mutant p53 gene, DNA contents and conventional clinicopathological prognostic variables in cases with endometrial carcinoma.
Osmanağaoğlu MA; Kadioğlu S; Osmanağaoğlu S; Bozkaya H; Reis A; Tekelioğlu Y
Eur J Gynaecol Oncol; 2005; 26(1):64-70. PubMed ID: 15755004
[TBL] [Abstract][Full Text] [Related]
29. Aneuploidy predicts outcome in patients with endometrial carcinoma and is related to lack of CDH13 hypermethylation.
Suehiro Y; Okada T; Okada T; Anno K; Okayama N; Ueno K; Hiura M; Nakamura M; Kondo T; Oga A; Kawauchi S; Hirabayashi K; Numa F; Ito T; Saito T; Sasaki K; Hinoda Y
Clin Cancer Res; 2008 Jun; 14(11):3354-61. PubMed ID: 18519763
[TBL] [Abstract][Full Text] [Related]
30. DNA index by image analysis in advanced endometrial carcinoma.
Geisler JP; Wiemann MC; Zhou Z; Miller GA; Geisler HE
J Surg Oncol; 1996 Oct; 63(2):91-4. PubMed ID: 8888800
[TBL] [Abstract][Full Text] [Related]
31. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
32. DNA ploidy status: its impact on early-stage endometrial adenocarcinoma.
Goodman A; Bell DA; Rice LW
Gynecol Oncol; 1993 Dec; 51(3):355-61. PubMed ID: 8112645
[TBL] [Abstract][Full Text] [Related]
33. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.
Salvesen HB; Iversen OE; Akslen LA
Clin Cancer Res; 1998 Nov; 4(11):2779-85. PubMed ID: 9829742
[TBL] [Abstract][Full Text] [Related]
34. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival.
del Vecchio MT; Lazzi S; Bruni A; Mangiavacchi P; Cevenini G; Luzi P
Pathol Res Pract; 1998; 194(5):325-33. PubMed ID: 9651945
[TBL] [Abstract][Full Text] [Related]
35. Effect of deoxyribonucleic acid ploidy status on survival of patients with carcinoma of the endometrium.
Dyas CH; Simmons TK; Ellis CN; Austin JM; Partridge EE; Kilgore LC; Reading C; Nelson K; Blakemore WS
Surg Gynecol Obstet; 1992 Feb; 174(2):133-6. PubMed ID: 1734571
[TBL] [Abstract][Full Text] [Related]
36. DNA ploidy may be a prognostic marker in stage I and II serous adenocarcinoma of the endometrium.
Pradhan M; Davidson B; Abeler VM; Danielsen HE; Tropé CG; Kristensen GB; Risberg BÅ
Virchows Arch; 2012 Sep; 461(3):291-8. PubMed ID: 22824999
[TBL] [Abstract][Full Text] [Related]
37. [Prognostic importance of selected molecular genetic immunohistochemical markers and DNA ploidy in endometrial cancer].
Kudela M; Pilka R; Lubuský M; Hejtmánek P; Dzubák P; Brychtová S
Ceska Gynekol; 2011 Jun; 76(3):194-9. PubMed ID: 21838149
[TBL] [Abstract][Full Text] [Related]
38. [DNA ploidy in epithelial ovarian cancer--an independent prognostic factor].
Tropé CG; Abeler V; Baekelandt M; Kaern J
Tidsskr Nor Laegeforen; 2000 Jan; 120(1):43-9. PubMed ID: 10815478
[TBL] [Abstract][Full Text] [Related]
39. Laminin-5 gamma2-chain expression and DNA ploidy as predictors of prognosis in endometrial carcinoma.
Lundgren C; Frankendal B; Silfverswärd C; Nilsson B; Tryggvason K; Auer G; Nordström B
Med Oncol; 2003; 20(2):147-56. PubMed ID: 12835517
[TBL] [Abstract][Full Text] [Related]
40. Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival.
Mauland KK; Wik E; Hoivik EA; Kusonmano K; Halle MK; Berg A; Haugland HK; Øyan AM; Kalland KH; Stefansson IM; Akslen LA; Krakstad C; Trovik J; Werner HM; Salvesen HB
Oncotarget; 2017 Feb; 8(6):9696-9707. PubMed ID: 28039471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
